Rajit Pahwa, MD
Critical Care Medicine · Lansing, MINPI 1689669590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $217 and has fallen 88.2% since, to $26 in 2024.
Across 41 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$149
- UCB, Inc.$110
- Boehringer Ingelheim$85
- Merck$72
- E.r. Squibb & Sons, L.L.C.$70
- Melinta Therapeutics, LLC$60
- plus $221 from 7 others
Across 9 payments — averaging $2186.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sage Therapeutics, LLC$20K
What the payments were for
- Food & beverage$75698%
- Education$132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 2 | $149 |
| UCB, Inc. | 6 | $110 |
| Boehringer Ingelheim | 5 | $85 |
| Merck | 5 | $72 |
| E.r. Squibb & Sons, L.L.C. | 5 | $70 |
| Melinta Therapeutics, LLC | 4 | $60 |
| AbbVie(2 entities) | 4 | $58 |
| Johnson & Johnson | 3 | $42 |
| Pfizer | 2 | $31 |
| La Jolla Pharmaceutical Company | 2 | $30 |
| Pyros Pharmaceuticals, Inc. | 1 | $26 |
| Insmed, Inc. | 1 | $20 |
| Gilead | 1 | $16 |
How this compares
$769 in reported general payments places this provider in the 60th percentile of 177 critical care medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Lansing
- Mujahed AbbasLansing$28K
- Angel Peralta-AvilaDetroit$147K
- Moumen AsbahiTroy$81K
- Abdulrazak AlchakakiSouthfield$19K
- Narayana GandhamSaint Joseph$18K
- Sara MirzaAnn Arbor$12K
- Asker AsmiRiverview$11K
- Andrew EasowDearborn$10K
- Jeffery WiltGrand Rapids$10K
- Furqan SiddiqiSaint Joseph$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.